Accessibility Menu
 

Vicapsys Life Sciences

(OTC) VICP

Current Price$1.50
Market Cap$48.56M
Since IPO (2018)-57%
5 Year+0%
1 Year-50%
1 Month+0%

Vicapsys Life Sciences Financials at a Glance

Market Cap

$48.56M

Revenue (TTM)

$0.00

Net Income (TTM)

$844.15K

EPS (TTM)

$-0.02

P/E Ratio

-60.24

Dividend

$0.00

Beta (Volatility)

34768.31 (High)

Price

$1.50

Volume

3

Open

$1.50

Previous Close

$1.50

Daily Range

$1.50 - $1.50

52-Week Range

$1.00 - $1.77

VICP News

No articles available.

VICP: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vicapsys Life Sciences

Industry

Biotechnology

Employees

2

CEO

Federico Luis Pier, MBA

Headquarters

Cumming, GA 30024, US

VICP Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

20%

Return on Assets

-111%

Earnings Yield

-1.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$48.56M

Shares Outstanding

32.37M

Volume

3

Short Interest

0.00%

Avg. Volume

0.066

Financials (TTM)

Gross Profit

$0.00

Operating Income

$813.84K

EBITDA

$900.14K

Operating Cash Flow

$121.66K

Capital Expenditure

$4.00

Free Cash Flow

$121.66K

Cash & ST Invst.

$11.60K

Total Debt

$578.95K

Vicapsys Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$48.56M

N/A

Market Cap/Employee

$24.28M

N/A

Employees

2

N/A

Net Income

$181.43K

+44.5%

EBITDA

$173.18K

+40.4%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Net Cash

$573.07K

-24.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$578.95K

+25.2%

Return on Assets

-111.31%

N/A

Return on Invested Capital

19.61%

N/A

Free Cash Flow

$145.77K

+235.7%

Operating Cash Flow

$145.78K

+235.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INNMFAmplia Therapeutics Limited
$0.08+0.00%
ZIVOZIVO Bioscience, Inc.
$9.30+7.14%
ACHFFArch Biopartners Inc.
$0.40-9.62%
SNANFSona Nanotech Inc.
$0.23-26.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
NVDANvidia
$172.70-0.03%
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%

Questions About VICP

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.